首页 › 基金 › Patient Square Capital LP › ZNTL
Patient Square Capital LP 对 ZNTL 的持仓历史
ZENTALIS PHARMACEUTICALS INC · 医疗保健
Patient Square Capital LP 在 Q3 2026 的 13F 申报中披露持有 ZNTL(ZENTALIS PHARMACEUTICALS INC)2,007,485 股,市值约 US$5.6M,约占其申报组合的 0.89%,在其申报持仓中市值排名第 21 位。 Patient Square Capital LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Patient Square Capital LP 对 ZNTL 的持仓演变
Patient Square Capital LP 于 Q3 2026 首次披露 ZNTL 持仓:2,007,485 股(约 US$5.6M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 2.01M | $5.56M | 新进 |
关于 ZNTL 与 13F 数据
ZNTL(ZENTALIS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 ZNTL,申报仓位最大的包括:5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ZNTL 的基金
- 5AM Venture Management, LLC 3.95M 股 · $19.15M · Q2 2026
- Opaleye Management Inc. 1.41M 股 · $6.85M · Q2 2026
- Decheng Capital LLC 1.32M 股 · $6.42M · Q2 2026
- Ishara Investments LP 1.02M 股 · $4.97M · Q2 2026
- PFIZER INC 953.83K 股 · $2.58M · Q3 2026
- Squadron Capital Management LLC 426.00K 股 · $2.07M · Q2 2026
更多关于 Patient Square Capital LP
常见问题
How long has Patient Square Capital LP held ZNTL?
Patient Square Capital LP has disclosed ZNTL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Patient Square Capital LP's current position in ZNTL?
As of Q3 2026, Patient Square Capital LP holds 2.01M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $5.56M, representing 0.89% of its reported portfolio and ranking #21.
Has Patient Square Capital LP been buying or selling ZNTL?
In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in ZNTL.
Which other funds hold ZNTL?
Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Decheng Capital LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.